Actionable news
0
All posts from Actionable news
Actionable news in TRIV: TRIVASCULAR TECHNOLOGIES Inc COMMON STOCK,

Prospectuses and communications, business combinations

BGCOLOR="WHITE">

Filed by: TriVascular Technologies, Inc.

Pursuant to Rule 425 under the Securities Act of 1933

and deemed filed pursuant to Rule 14a-12 of the

Securities Exchange Act of 1934

Subject Company: TriV ascular Technologies, Inc.

Commission File No.: 001-36419

The following is a series of questions and answers being provided to TriVascular employees

QUESTIONS AND ANSWERS ABOUT ANNOUNCED MERGER AGREEMENT WITH ENDOLOGIX

The Q&As in this document are intended to address commonly asked questions in summary format and do not create contractual rights or amend any plans or benefit programs. As always, the terms of the underlying benefit plans, and the merger agreement with respect to items addressed in the merger agreement, control in the event of a conflict with this summary, and TriVascular and Endologix reserve the right to amend or terminate their benefit plans in accordance with the terms of the plans and applicable law. Nothing in this document should be construed as an employment contract. The employment relationship between TriVascular and its employees is employment at will.

Forward-Looking Statements

This communication includes statements that may be forward-looking statements. The words believe, expect, anticipate, project and similar expressions, among others, generally identify forward-looking statements. Endologix and TriVascular caution that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the likelihood that the transaction is consummated on a timely basis or at all, including whether the conditions required to complete the transaction will be met...


More